Principal Securities’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$126 Hold
9
﹤0.01% 3633
2025
Q1
$173 Hold
9
﹤0.01% 3473
2024
Q4
$173 Buy
+9
New +$173 ﹤0.01% 3468